查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586367

數位治療市場、規模、佔有率、趨勢、行業分析報告：按收入模式、按應用、按最終用戶、按地區 - 市場預測，2024-2032

Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model, Application, End Users, and Region - Market Forecast, 2024-2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，數位治療市場預計將達到 706.3 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

數位治療市場的成長是由全球網路存取不斷增加所推動的，不僅在已開發國家，而且在新興市場也是如此。例如，根據《我們的數據世界》的統計，2000年，亞洲有7%的人口可以上網，而非洲只有3%。 2016年，網路接取人口比例大幅提升，韓國、日本91%的人口接取互聯網，丹麥、挪威97%的人口接取網路。 6年後，也就是2022年，非洲主要地區有81%的人口將連上網路。

政府對整個生態系統進行數位化的舉措和激勵措施預計將在預測期內推動數位治療市場的發展。增加政府對醫療保健行業的資助以及引入醫療保健行業數位化計劃預計將在研究期間推動數位治療市場的發展。例如，2023 年 8 月，印度政府在 Ayushman Bharat 數位使命 (ABDM) 下推出了數位健康激勵計畫 (DHIS)，以鼓勵數位健康、實驗室和健康科技公司的採用。數位健康獎勵計畫為新的健康科技新創公司提供高達 4 兆印度盧比的誘因。

數位治療服務的主要消費者是僱主和病人。領先的公司開始在其員工套餐中添加治療服務，提供生活方式管理、憂鬱症和高血壓相關服務。患有糖尿病、心血管疾病等慢性疾病的患者可以使用該服務進行日常諮詢。

數位治療市場報告亮點

收入模型分析預測，訂閱細分市場將在全球市場顯著成長。這種成長歸因於與基於訂閱的收入模式相關的主要優勢。

最終用戶分析預測，隨著全球主要公司推出數位治療套餐服務，僱主細分市場將在 2024 年至 2032 年期間主導市場。

由於擁有網路存取和先進數位化的人口比例很高，到 2023 年，北美將主導數位治療市場。

由於醫療保健產業的監管支持和數位化舉措，印度的數位治療市場預計將大幅成長。

主要市場參與者包括Proteus Digital Health, Inc.、Fitbit, Inc.、Pear Therapeutics, Inc.、Kaia Health、Happify, Inc.、Medtronic Plc.、Omada Health, Inc.、Livongo Health, Inc.、 Voluntis Inc.、Resmed, Inc.、Welldoc, Inc.、2Morrow Inc.、Canary Health 和 Mindable Health GmbH。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第 4 章全球數位治療市場洞察

  • 市場快照
  • 數位治療市場動態
    • 促進因素和機會
      • 服務導向的軟體的進步推動市場成長
      • 每日上網時間的增加正在推動市場規模的擴大
    • 阻礙因素和課題
      • 缺乏資本投資
  • PESTEL 分析
  • 數位治療市場的趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第 5 章全球數位治療市場：依收入模式劃分

  • 主要發現
  • 簡介
  • 訂閱
  • 以價值為基礎
  • 一次購買

第 6 章全球數位治療市場：依應用劃分

  • 主要發現
  • 簡介
  • 糖尿病
  • 肥胖
  • 腦血管疾病（CVD）
  • 中樞神經系統疾病
  • 呼吸系統疾病
  • 禁止吸煙
  • 生活方式管理
  • 為了預防
  • 其他

第 7 章全球數位治療市場：依最終使用者劃分

  • 主要發現
  • 簡介
  • 病人
  • 提供者
  • 付款人
  • 僱主
  • 其他

第 8 章全球數位治療市場：按地區

  • 主要發現
  • 簡介
    • 數位治療市場評估：按地區劃分，2019-2032 年
  • 北美
    • 北美：依收入模式劃分，2019-2032 年
    • 北美：依申請劃分，2019-2032 年
    • 北美：依最終使用者劃分，2019-2032 年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依收入模式劃分，2019-2032 年
    • 歐洲：依申請劃分，2019-2032 年
    • 歐洲：依最終使用者劃分，2019-2032 年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 亞太地區：依收入模式劃分，2019-2032 年
    • 亞太地區：依應用程式劃分，2019-2032 年
    • 亞太地區：依最終使用者劃分，2019-2032 年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東/非洲
    • 中東和非洲：依收入模式劃分，2019-2032 年
    • 中東與非洲：依申請劃分，2019-2032 年
    • 中東和非洲：按最終用戶劃分，2019-2032 年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東/非洲
  • 拉丁美洲
    • 拉丁美洲：依所得模式劃分，2019-2032 年
    • 拉丁美洲：依申請劃分，2019-2032 年
    • 拉丁美洲：依最終使用者劃分，2019-2032 年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區

第9章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章公司簡介

  • Proteus Digital Health, Inc.
  • Fitbit Inc.
  • Pear Therapeutics, Inc.
  • Kaia Health
  • Happify, Inc.
  • Medtronic Plc.
  • Omada Health, Inc.
  • Livongo Health, Inc.
  • Voluntis, Inc.
  • Resmed, Inc.
  • Welldoc, Inc.
  • 2Morrow Inc.
  • Canary Health
  • Mindable Health GmbH.
Product Code: PM1908

The digital therapeutics market size is expected to reach USD 70.63 billion by 2032, according to a new study by Polaris Market Research. The report "Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model (Subscription and Value-Based), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The digital therapeutics market growth is driven by increasing internet access globally in developed as well as developing countries. For instance, according to statistics of Our World in Data, in 2000, 7% of the Asian population had access to the internet, while just 3% of the African region was online. By 2016, the population share with internet access increased significantly, with 91% of the population in South Korea and Japan having internet access and 97% of the population in Denmark and Norway online. After six years, in 2022, major regions of Africa witnessed 81% of the population share gain internet access.

Government initiatives and incentives in order to digitalize the whole ecosystem are anticipated to boost the digital therapeutics market during the forecast years. Increased government funding in the healthcare sector and the introduction of schemes for the digitalization of the healthcare sector are expected to fuel the digital therapeutics market during the study time. For instance, in August 2023, the government of India introduced the Digital Health Incentive Scheme (DHIS) under the Ayushman Bharat Digital Mission (ABDM) to encourage the adoption of digital health, laboratories, and health tech companies. In the digital health incentive scheme, new health tech startups will be offered incentives up to 4 crore INR.

Employers and patients are the major consumers of digital therapeutic services. Major companies have started adding therapies as services in their employee packages, providing lifestyle management, depression, and hypertension-related services. Patients with chronic diseases, such as diabetes and cardiovascular diseases, can use the services for day-to-day consultation.

Digital Therapeutics Market Report Highlights

By revenue model analysis, the subscription segment is anticipated to experience substantial growth in the global market. This growth is attributed to major advantages that are associated with the subscription-based revenue model.

By end users analysis, the employers segment is anticipated to dominate the market from 2024 to 2032 due to major companies globally having started including digital therapeutics packages in their services.

In 2023, North America dominated the digital therapeutics market due to the large share of the population having internet access and increasing digitalization.

The digital therapeutics market in India is projected for substantial growth due to the regulatory support and initiatives for the digitalization of the healthcare sector.

The key market players are Proteus Digital Health, Inc.; Fitbit, Inc.; Pear Therapeutics, Inc.; Kaia Health; Happify, Inc.; Medtronic Plc.; Omada Health, Inc.; Livongo Health, Inc.; Voluntis Inc.; Resmed, Inc.; Welldoc, Inc.; 2Morrow Inc.; Canary Health; and Mindable Health GmbH.

Polaris Market Research has segmented the digital therapeutics market report based on revenue model, application, end users, and region:

By Revenue Model Outlook (Revenue - USD billion, 2019-2032)

  • Subscription
  • Value-based
  • One Time Purchase

By Application Outlook (Revenue - USD billion, 2019-2032)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Lifestyle Management
  • Preventive Applications
  • Others

By End Users Outlook (Revenue - USD billion, 2019-2032)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

By Regional Outlook (Revenue - USD billion, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of the Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Digital Therapeutics Market Insights

  • 4.1. Digital Therapeutics Market - Market Snapshot
  • 4.2. Digital Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Service Oriented Software Are Driving Market Growth
      • 4.2.1.2. Increase in Daily Hours Spend on Internet is Propelling Market Size
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Capital Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Digital Therapeutics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Digital Therapeutics Market, by Revenue Model

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • 5.3. Subscription
    • 5.3.1. Global Digital Therapeutics Market, by Subscription, by Region, 2019-2032 (USD billion)
  • 5.4. Value Based
    • 5.4.1. Global Digital Therapeutics Market, by Value Based, by Region, 2019-2032 (USD billion)
  • 5.5. One Time Purchase
    • 5.5.1. Global Digital Therapeutics Market, by One Time Purchase, by Region, 2019-2032 (USD billion)

6. Global Digital Therapeutics Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • 6.3. Diabetes
    • 6.3.1. Global Digital Therapeutics Market, by Diabetes, by Region, 2019-2032 (USD billion)
  • 6.4. Obesity
    • 6.4.1. Global Digital Therapeutics Market, by Obesity, by Region, 2019-2032 (USD billion)
  • 6.5. CVD
    • 6.5.1. Global Digital Therapeutics Market, by CVD, by Region, 2019-2032 (USD billion)
  • 6.6. CNS Disease
    • 6.6.1. Global Digital Therapeutics Market, by CNS Disease, by Region, 2019-2032 (USD billion)
  • 6.7. Respiratory Disease
    • 6.7.1. Global Digital Therapeutics Market, by CVD, by Respiratory Disease, 2019-2032 (USD billion)
  • 6.8. Smoking Cessation
    • 6.8.1. Global Digital Therapeutics Market, by Smoking Cessation, by Region, 2019-2032 (USD billion)
  • 6.9. Lifestyle Management
    • 6.9.1. Global Digital Therapeutics Market, by Lifestyle Management, by Region, 2019-2032 (USD billion)
  • 6.10. Preventive Applications
    • 6.10.1. Global Digital Therapeutics Market, by Preventive Applications, by Region, 2019-2032 (USD billion)
  • 6.11. Others
    • 6.11.1. Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

7. Global Digital Therapeutics Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 7.3. Patients
    • 7.3.1. Global Digital Therapeutics Market, by Patients, by Region, 2019-2032 (USD billion)
      • 7.3.1.1.
  • 7.4. Providers
    • 7.4.1. Global Digital Therapeutics Market, by Providers, by Region, 2019-2032 (USD billion)
  • 7.5. Payers
    • 7.5.1. Global Digital Therapeutics Market, by Payers, by Region, 2019-2032 (USD billion)
  • 7.6. Employers

Global Digital Therapeutics Market, by Employers, by Region, 2019-2032 (USD billion)

  • 7.7. Others

Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

8. Global Digital Therapeutics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Digital Therapeutics Market Assessment, By Geography, 2019-2032 (USD billion)
  • 8.3. Digital Therapeutics Market - North America
    • 8.3.1. North America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.3.2. North America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.3.3. North America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.3.4. Digital Therapeutics Market - U.S.
      • 8.3.4.1. U.S.: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.3.4.2. U.S.: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.3.4.3. U.S.: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.3.5. Digital Therapeutics Market - Canada
      • 8.3.5.1. Canada: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.3.5.2. Canada: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.3.5.3. Canada: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.4. Digital Therapeutics Market - Europe
    • 8.4.1. Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.4.2. Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.4.3. Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.4. Digital Therapeutics Market - UK
      • 8.4.4.1. UK: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.4.2. UK: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.4.3. UK: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.5. Digital Therapeutics Market - France
      • 8.4.5.1. France: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.5.2. France: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.5.3. France: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.6. Digital Therapeutics Market - Germany
      • 8.4.6.1. Germany: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.6.2. Germany: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.6.3. Germany: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.7. Digital Therapeutics Market - Italy
      • 8.4.7.1. Italy: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.7.2. Italy: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.7.3. Italy: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.8. Digital Therapeutics Market - Spain
      • 8.4.8.1. Spain: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.8.2. Spain: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.8.3. Spain: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.9. Digital Therapeutics Market - Netherlands
      • 8.4.9.1. Netherlands: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.9.2. Netherlands: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.9.3. Netherlands: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.10. Digital Therapeutics Market - Russia
      • 8.4.10.1. Russia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.10.2. Russia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.10.3. Russia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.11. Digital Therapeutics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.11.2. Rest of Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.11.3. Rest of Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.5. Digital Therapeutics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.5.2. Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.5.3. Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.4. Digital Therapeutics Market - China
      • 8.5.4.1. China: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.4.2. China: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.4.3. China: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.5. Digital Therapeutics Market - India
      • 8.5.5.1. India: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.5.2. India: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.5.3. India: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.6. Digital Therapeutics Market - Malaysia
      • 8.5.6.1. Malaysia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.6.2. Malaysia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.6.3. Malaysia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.7. Digital Therapeutics Market - Japan
      • 8.5.7.1. Japan: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.7.2. Japan: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.7.3. Japan: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.8. Digital Therapeutics Market - Indonesia
      • 8.5.8.1. Indonesia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.8.2. Indonesia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.8.3. Indonesia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.9. Digital Therapeutics Market - South Korea
      • 8.5.9.1. South Korea: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.9.2. South Korea: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.9.3. South Korea: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.10. Digital Therapeutics Market - Australia
      • 8.5.10.1. Australia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.10.2. Australia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.10.3. Australia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.11. Digital Therapeutics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.11.2. Rest of Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.11.3. Rest of Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.6. Digital Therapeutics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.6.2. Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.6.3. Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.4. Digital Therapeutics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.4.2. Saudi Arabia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.4.3. Saudi Arabia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.5. Digital Therapeutics Market - UAE
      • 8.6.5.1. UAE: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.5.2. UAE: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.5.3. UAE: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.6. Digital Therapeutics Market - Israel
      • 8.6.6.1. Israel: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.6.2. Israel: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.6.3. Israel: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.7. Digital Therapeutics Market - South Africa
      • 8.6.7.1. South Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.7.2. South Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.7.3. South Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.8. Digital Therapeutics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.8.2. Rest of Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.8.3. Rest of Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.7. Digital Therapeutics Market - Latin America
    • 8.7.1. Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.7.2. Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.7.3. Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.4. Digital Therapeutics Market - Mexico
      • 8.7.4.1. Mexico: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.4.2. Mexico: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.4.3. Mexico: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.5. Digital Therapeutics Market - Brazil
      • 8.7.5.1. Brazil: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.5.2. Brazil: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.5.3. Brazil: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.6. Digital Therapeutics Market - Argentina
      • 8.7.6.1. Argentina: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.6.2. Argentina: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.6.3. Argentina: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.7. Digital Therapeutics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.7.2. Rest of Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.7.3. Rest of Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Proteus Digital Health, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Fitbit Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Pear Therapeutics, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Kaia Health
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Happify, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Medtronic Plc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Omada Health, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Livongo Health, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Voluntis, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Resmed, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Welldoc, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. 2Morrow Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Canary Health
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Mindable Health GmbH.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development

List of Tables:

  • Table 1 Global Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 2 Global Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 3 Global Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 4 North America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 5 North America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 6 North America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 7 U.S.: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 8 U.S.: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 9 U.S.: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 10 Canada: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 11 Canada: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 12 Canada: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 13 Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 14 Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 15 Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 16 UK: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 17 UK: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 18 UK: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 19 France: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 20 France: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 21 France: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 22 Germany: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 23 Germany: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 24 Germany: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 25 Italy: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 26 Italy: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 27 Italy: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 28 Spain: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 29 Spain: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 30 Spain: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 31 Netherlands: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 32 Netherlands: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 33 Netherlands: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 34 Russia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 35 Russia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 36 Russia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 37 Rest of Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 38 Rest of Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 39 Rest of Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 40 Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 41 Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 42 Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 43 China: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 44 China: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 45 China: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 46 India: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 47 India: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 48 India: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 49 Malaysia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 50 Malaysia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 51 Malaysia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 52 Japan: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 53 Japan: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 54 Japan: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 55 Indonesia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 56 Indonesia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 57 Indonesia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 58 South Korea: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 59 South Korea: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 60 South Korea: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 61 Australia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 62 Australia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 63 Australia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 64 Rest of Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 65 Rest of Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 66 Rest of Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 67 Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 68 Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 69 Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 70 Saudi Arabia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 71 Saudi Arabia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 72 Saudi Arabia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 73 UAE: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 74 UAE: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 75 UAE: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 76 Israel: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 77 Israel: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 78 Israel: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 79 South Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 80 South Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 81 South Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 82 Rest of Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 83 Rest of Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 84 Rest of Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 85 Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 86 Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 87 Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 88 Mexico: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 89 Mexico: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 90 Mexico: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 91 Brazil: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 92 Brazil: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 93 Brazil: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 94 Argentina: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 95 Argentina: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 96 Argentina: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 97 Rest of Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 98 Rest of Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 99 Rest of Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)

List of Figures:

  • Figure 1. Global Digital Therapeutics Market, 2019-2032 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Revenue Model
  • Figure 7. Global Digital Therapeutics Market, by Revenue Model, 2023 & 2032 (USD billion)
  • Figure 8. Market by Application
  • Figure 9. Global Digital Therapeutics Market, by Application, 2023 & 2032 (USD billion)
  • Figure 10. Market by End User
  • Figure 11. Global Digital Therapeutics Market, by End User, 2023 & 2032 (USD billion)
  • Figure 12. Global Digital Therapeutics Market Assessment, By Geography, 2019-2032 (USD billion)
  • Figure 13. Strategic Analysis - Global Digital Therapeutics Market